Close Menu
  • Home
  • AI
  • Education
  • Entertainment
  • Food Health
  • Health
  • Sports
  • Tech
  • Well Being

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

Anthropic CEO says AI backlash is ‘fundamentally a crisis of trust’

August 16, 2026

Dario Amodei Says AI Needs to ‘Actually’ Cure Cancer to Win Over Public

August 16, 2026

The Hack Dropbox’s Co-CEO Uses to Decide Which Meetings to Skip

August 16, 2026
Facebook X (Twitter) Instagram
  • Home
  • About Us
  • Advertise With Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram
IQ Times Media – Smart News for a Smarter YouIQ Times Media – Smart News for a Smarter You
  • Home
  • AI
  • Education
  • Entertainment
  • Food Health
  • Health
  • Sports
  • Tech
  • Well Being
IQ Times Media – Smart News for a Smarter YouIQ Times Media – Smart News for a Smarter You
Home » India’s Healthify eyes more weight-loss drugmaker tie-ups after Novo Nordisk pact
Health

India’s Healthify eyes more weight-loss drugmaker tie-ups after Novo Nordisk pact

IQ TIMES MEDIABy IQ TIMES MEDIAJuly 1, 2007No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


By Rishika Sadam and Abhirami G

BENGALURU, Dec 5 (Reuters) – Indian health-tech startup Healthify is in talks to partner with more weight-loss drugmakers to offer ​health, nutrition and lifestyle coaching, after signing a deal with Novo ‌Nordisk’s India unit, its chief executive said.

The deal marks Healthify’s first such partnership with a drugmaker, ‌and it hopes similar agreements will boost its paid subscriber base.

Healthify, which provides health metric tracking along with nutrition and fitness advice, launched a patient-support programme this week through which it offers coaching services to users prescribed Novo’s weight-loss therapies.

“Our vision is ⁠to be the world’s ‌biggest patient support provider for all GLP (GLP-1 receptor agonists are a class of weight-loss drugs) companies in every market,” CEO Tushar ‍Vashisht told Reuters.

The patient-support programme is part of Healthify’s broader weight-loss initiative, which already accounts for a double-digit share of its revenue, Vashisht said.

Healthify has about 45 million users globally, ​he added, while its paid subscriber base is in the six-digit figures. ‌The company declined to provide a precise number.

India has emerged as a key battleground for obesity treatments, with Novo and U.S. drugmaker Eli Lilly competing for a slice of a global market expected to reach $150 million annually by the end of the decade.

Local generic drugmakers are also expected to enter the segment after ⁠the patent for semaglutide, the active ingredient in ​Novo’s obesity drug Wegovy, expires in 2026.

Healthify, which ​has so far raised $122 million, said its GLP-1 weight-loss programme is its fastest-growing offering. It expects more than a third of its ‍paid subscriptions to ⁠come from the programme over the next year, with about half of that growth from new users and 15% from existing subscribers.

The company also ⁠plans to roll out its Novo-linked support programme in other geographies, Vashisht said, but declined to ‌elaborate.

(Reporting by Rishika Sadam in Hyderabad and Abhirami G from Bengaluru; ‌Editing by Dhanya Skariachan and Sonia Cheema)



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
IQ TIMES MEDIA
  • Website

Related Posts

What an expert on the gut microbiome eats in a day

March 26, 2026

Wegovy maker Novo sharpens consumer focus with board role for Mars CEO

March 26, 2026

CDC report finds US smoking rate continues to plummet as vape use rises

March 26, 2026
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

UK’s Burnham says death of ex-Cambridge professor Jason Arday is a tragedy

August 15, 2026

Police seek multiple suspects at Virginia State University shooting

August 15, 2026

British sociologist Jason Arday found dead after Cambridge resignation

August 14, 2026

Defense Dept. history textbook inspired by classical Christian schools

August 14, 2026
Education

UK’s Burnham says death of ex-Cambridge professor Jason Arday is a tragedy

By IQ TIMES MEDIAAugust 15, 20260

LONDON (AP) — Britain’s prime minister called for reflection on Saturday after a Black professor…

Police seek multiple suspects at Virginia State University shooting

August 15, 2026

British sociologist Jason Arday found dead after Cambridge resignation

August 14, 2026

Defense Dept. history textbook inspired by classical Christian schools

August 14, 2026
IQ Times Media – Smart News for a Smarter You
Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
  • Home
  • About Us
  • Advertise With Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2026 iqtimes. Designed by iqtimes.

Type above and press Enter to search. Press Esc to cancel.